To analyze changes in T-helper (Th) subsets, T-regulatory (Treg) cell percentages and function, and mRNA levels of immunologically relevant molecules during a 24-month follow-up after alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (RRMS).
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months
COCCO, ELEONORA;
2016-01-01
Abstract
To analyze changes in T-helper (Th) subsets, T-regulatory (Treg) cell percentages and function, and mRNA levels of immunologically relevant molecules during a 24-month follow-up after alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis (RRMS).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
NEURIMMINFL2015007526.pdf
accesso aperto
Tipologia:
versione editoriale
Dimensione
405.27 kB
Formato
Adobe PDF
|
405.27 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
